Proposed collection; 60-day comment request Information Program on Clinical Trials: Maintaining a Registry and Results Databank (NLM), 32968-32969 [2015-14169]
Download as PDF
32968
Federal Register / Vol. 80, No. 111 / Wednesday, June 10, 2015 / Notices
Contact Person: Joseph Thomas Peterson,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9694, petersonjt@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Radiation Therapy and Biology
SBIR/STTR.
Date: July 8–9, 2015.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 5, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–14186 Filed 6–9–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed collection; 60-day comment
request Information Program on
Clinical Trials: Maintaining a Registry
and Results Databank (NLM)
In compliance with the
requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Library of Medicine (NLM),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval. This summary
describes the existing information
collection at ClinicalTrials.gov, for
which an extension is requested; it does
not include any changes to the
SUMMARY:
Health operates ClinicalTrials.gov,
which was established as a clinical trial
registry under section 113 of the Food
and Drug Administration Modernization
Act of 1997 (Pub. L. 105–115) and was
expanded to include a results data bank
by Title VIII of the Food and Drug
Administration Amendments Act of
2007 (FDAAA). ClinicalTrials.gov
collects registration and results
information for clinical trials and other
types of clinical studies (e.g.,
observational studies and patient
registries) with the objectives of
enhancing patient enrollment and
providing a mechanism for tracking
subsequent progress of clinical studies,
to the benefit of public health. It is
widely used by patients, physicians,
and medical researchers; in particular
those involved in clinical research.
While many clinical studies are
registered and submit results
information voluntarily, FDAAA
requires the registration of certain
applicable clinical trials of drugs and
devices and the submission of results
information for completed applicable
clinical trials of drugs and devices that
are approved, licensed, or cleared by the
Food and Drug Administration.
Beginning in 2009, results information
was required to include information
about serious and frequent adverse
events.
This extension request does not
include any changes to the information
submission requirements for
ClinicalTrials.gov that were proposed in
the Notice of Proposed Rulemaking on
Clinical Trial Registration and Results
Submission that was issued on
November 21, 2014 and for which the
public comment period closed on March
23, 2015 (79 FR 225, Nov. 21, 2014). The
NIH is continuing to review submitted
public comments as it prepares the final
rule. The NIH will make any
corresponding changes to the
ClinicalTrials.gov information
collection via separate procedure.
OMB approval is requested for 3
years. The total estimated annualized
cost to respondents is $49,399,851. The
total estimated annualized burden hours
are 682,535.
information collection that were
proposed in the Notice of Proposed
Rulemaking on Clinical Trial
Registration and Results Submission
that was issued on November 21, 2014
(79 FR 225, Nov. 21, 2014).
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and For Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: David Sharlip, Office of
Administrative and Management
Analysis Services, National Library of
Medicine, Building 38A, Room B2N12,
8600 Rockville Pike, Bethesda, MD
20894, or call non-toll-free number (301)
402–9680, or Email your request,
including your address to: sharlipd@
mail.nih.gov Formal requests for
additional plans and instruments must
be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Information
Program on Clinical Trials: Maintaining
a Registry and Results Databank (NLM),
0925–0586, Expiration Date: 08/31/
2015, EXTENSION, National Library of
Medicine (NLM), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The National Institutes of
asabaliauskas on DSK5VPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Submission type
PRS Account ...................................................................................................
Initial Registration ............................................................................................
Updates ............................................................................................................
Initial Results ...................................................................................................
Updates ............................................................................................................
VerDate Sep<11>2014
16:46 Jun 09, 2015
Jkt 235001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Number of
response per
respondent
5,700
23,000
23,000
3,700
3,700
E:\FR\FM\10JNN1.SGM
1
1
8
1
2
10JNN1
Average
time per
response
15/60
7
2
25
8
Annual
hour
burden
1,425
161,000
368,000
92,500
59,200
32969
Federal Register / Vol. 80, No. 111 / Wednesday, June 10, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
response per
respondent
Number of
respondents
Submission type
Average
time per
response
Annual
hour
burden
Certification to Delay Results ..........................................................................
Extension Request ...........................................................................................
700
30
1
1
30/60
2
350
60
Total ..........................................................................................................
33,130
........................
........................
682,535
Dated: June 4, 2015.
David Sharlip,
Project Clearance Liaison, NLM, NIH.
[FR Doc. 2015–14169 Filed 6–9–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Corneal Diseases, Membrane
Transport, and Ocular Cancer.
Date: June 22, 2015.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alessandra C Rovescalli,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Rm 5205
MSC7846, Bethesda, MD 20892, (301) 435–
1021, rovescaa@mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Biostatistical Methods and Research Design
Study Section.
Date: June 26, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
VerDate Sep<11>2014
16:46 Jun 09, 2015
Jkt 235001
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
Bethesda, MD 20892, 301–435–1116, kozelp@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Glioblastomas, Multiple Sclerosis,
Viruses, and Psychiatric Disorders.
Date: June 30, 2015.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Samuel C Edwards, Ph.D.,
IRG CHIEF, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR14–066:
Limited Competition: Specific Pathogen Ffee
Macaque Colonies.
Date: June 30, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cancer Drug Development and
Therapeutics.
Date: July 8–9, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
Behavioral and Social Consequences of HIV/
AIDS Study Section.
Date: July 9–10, 2015.
Time: 8:00 a.m. to 5:00 p.m.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW., Washington, DC 20036.
Contact Person: Mark P. Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–806–
6596, rubertm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 4, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–14170 Filed 6–9–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR part 404 to
achieve expeditious commercialization
of results of federally-funded research
and development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by writing to the
indicated licensing contact at the Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301–
496–7057; fax: 301–402–0220. A signed
Confidential Disclosure Agreement will
SUMMARY:
E:\FR\FM\10JNN1.SGM
10JNN1
Agencies
[Federal Register Volume 80, Number 111 (Wednesday, June 10, 2015)]
[Notices]
[Pages 32968-32969]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14169]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed collection; 60-day comment request Information Program
on Clinical Trials: Maintaining a Registry and Results Databank (NLM)
SUMMARY: In compliance with the requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Library of Medicine
(NLM), National Institutes of Health (NIH), will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval. This summary
describes the existing information collection at ClinicalTrials.gov,
for which an extension is requested; it does not include any changes to
the information collection that were proposed in the Notice of Proposed
Rulemaking on Clinical Trial Registration and Results Submission that
was issued on November 21, 2014 (79 FR 225, Nov. 21, 2014).
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments and For Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: David
Sharlip, Office of Administrative and Management Analysis Services,
National Library of Medicine, Building 38A, Room B2N12, 8600 Rockville
Pike, Bethesda, MD 20894, or call non-toll-free number (301) 402-9680,
or Email your request, including your address to: sharlipd@mail.nih.gov
Formal requests for additional plans and instruments must be requested
in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: Information Program on Clinical Trials:
Maintaining a Registry and Results Databank (NLM), 0925-0586,
Expiration Date: 08/31/2015, EXTENSION, National Library of Medicine
(NLM), National Institutes of Health (NIH).
Need and Use of Information Collection: The National Institutes of
Health operates ClinicalTrials.gov, which was established as a clinical
trial registry under section 113 of the Food and Drug Administration
Modernization Act of 1997 (Pub. L. 105-115) and was expanded to include
a results data bank by Title VIII of the Food and Drug Administration
Amendments Act of 2007 (FDAAA). ClinicalTrials.gov collects
registration and results information for clinical trials and other
types of clinical studies (e.g., observational studies and patient
registries) with the objectives of enhancing patient enrollment and
providing a mechanism for tracking subsequent progress of clinical
studies, to the benefit of public health. It is widely used by
patients, physicians, and medical researchers; in particular those
involved in clinical research. While many clinical studies are
registered and submit results information voluntarily, FDAAA requires
the registration of certain applicable clinical trials of drugs and
devices and the submission of results information for completed
applicable clinical trials of drugs and devices that are approved,
licensed, or cleared by the Food and Drug Administration. Beginning in
2009, results information was required to include information about
serious and frequent adverse events.
This extension request does not include any changes to the
information submission requirements for ClinicalTrials.gov that were
proposed in the Notice of Proposed Rulemaking on Clinical Trial
Registration and Results Submission that was issued on November 21,
2014 and for which the public comment period closed on March 23, 2015
(79 FR 225, Nov. 21, 2014). The NIH is continuing to review submitted
public comments as it prepares the final rule. The NIH will make any
corresponding changes to the ClinicalTrials.gov information collection
via separate procedure.
OMB approval is requested for 3 years. The total estimated
annualized cost to respondents is $49,399,851. The total estimated
annualized burden hours are 682,535.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Submission type Number of response per Average time Annual hour
respondents respondent per response burden
----------------------------------------------------------------------------------------------------------------
PRS Account..................................... 5,700 1 15/60 1,425
Initial Registration............................ 23,000 1 7 161,000
Updates......................................... 23,000 8 2 368,000
Initial Results................................. 3,700 1 25 92,500
Updates......................................... 3,700 2 8 59,200
[[Page 32969]]
Certification to Delay Results.................. 700 1 30/60 350
Extension Request............................... 30 1 2 60
---------------------------------------------------------------
Total....................................... 33,130 .............. .............. 682,535
----------------------------------------------------------------------------------------------------------------
Dated: June 4, 2015.
David Sharlip,
Project Clearance Liaison, NLM, NIH.
[FR Doc. 2015-14169 Filed 6-9-15; 8:45 am]
BILLING CODE 4140-01-P